NO20090164L - Kombinasjonsfremstillinger innbefattende SLV308 og en L-DOPA - Google Patents

Kombinasjonsfremstillinger innbefattende SLV308 og en L-DOPA

Info

Publication number: NO20090164L
Authority: NO; Norway
Prior art keywords: slv308; dopa; preparations including; combination preparations; simultaneous
Prior art date: 2006-06-16

Application number

NO20090164A

Other languages

English (en)

Norwegian (no)

Inventor

Gustaaf Johan Marie Van Scharrenburg

Martinus Th M Tulp

Andrew C Mccreary

Original Assignee

Solvay Pharm Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-16

Filing date

2009-01-12

Publication date

2009-01-14

2009-01-12 Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv

2009-01-14 Publication of NO20090164L publication Critical patent/NO20090164L/no

Links

YVPUUUDAZYFFQT-UHFFFAOYSA-N 7-(4-methylpiperazin-1-yl)-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C1=CC=CC2=C1OC(=O)N2 YVPUUUDAZYFFQT-UHFFFAOYSA-N 0.000 title abstract 2
WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title abstract 2
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
150000001204 N-oxides Chemical class 0.000 abstract 1
208000018737 Parkinson disease Diseases 0.000 abstract 1
208000005793 Restless legs syndrome Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
230000010249 dopaminergic function Effects 0.000 abstract 1
238000011084 recovery Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20090164A 2006-06-16 2009-01-12 Kombinasjonsfremstillinger innbefattende SLV308 og en L-DOPA NO20090164L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US81405106P	2006-06-16	2006-06-16
EP06115583		2006-06-16
PCT/EP2007/055955 WO2007144421A1 (en)	2006-06-16	2007-06-15	Combination preparations comprising slv308 and a l-dopa

Publications (1)

Publication Number	Publication Date
NO20090164L true NO20090164L (no)	2009-01-14

Family

ID=38434785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20090164A NO20090164L (no)	2006-06-16	2009-01-12	Kombinasjonsfremstillinger innbefattende SLV308 og en L-DOPA

Country Status (10)

Country	Link
EP (1)	EP2035002A1 (ja)
JP (1)	JP2009539941A (ja)
KR (1)	KR20090031908A (ja)
AU (1)	AU2007259255A1 (ja)
CA (1)	CA2654719A1 (ja)
EA (1)	EA015073B1 (ja)
IL (1)	IL195532A0 (ja)
MY (1)	MY148457A (ja)
NO (1)	NO20090164L (ja)
WO (1)	WO2007144421A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0027020D0 (en)	2000-11-03	2000-12-20	Univ Manchester	Treatment of movement disorders
US20090247537A1 (en) *	2008-03-25	2009-10-01	William Dale Overfield	Methods for preventing or treating bruxism using dopaminergic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7596407B2 (en) *	2004-03-26	2009-09-29	Solvay Pharmaceuticals, B.V.	Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
JP5081622B2 (ja) *	2004-09-21	2012-11-28	山▲東緑▼叶制▲薬▼有限公司	ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法
ES2318783T3 (es) *	2005-08-22	2009-05-01	Solvay Pharmaceuticals B.V.	N-oxidos como profarmacos de derivados de piperazina y piperadina.

2007
- 2007-06-15 CA CA002654719A patent/CA2654719A1/en not_active Abandoned
- 2007-06-15 EP EP07730193A patent/EP2035002A1/en not_active Withdrawn
- 2007-06-15 AU AU2007259255A patent/AU2007259255A1/en not_active Abandoned
- 2007-06-15 WO PCT/EP2007/055955 patent/WO2007144421A1/en active Search and Examination
- 2007-06-15 EA EA200970021A patent/EA015073B1/ru not_active IP Right Cessation
- 2007-06-15 KR KR1020097001024A patent/KR20090031908A/ko not_active Application Discontinuation
- 2007-06-15 JP JP2009514809A patent/JP2009539941A/ja active Pending
- 2007-06-15 MY MYPI20085078A patent/MY148457A/en unknown
2008
- 2008-11-26 IL IL195532A patent/IL195532A0/en unknown
2009
- 2009-01-12 NO NO20090164A patent/NO20090164L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2009539941A (ja)	2009-11-19
IL195532A0 (en)	2009-09-01
KR20090031908A (ko)	2009-03-30
EP2035002A1 (en)	2009-03-18
MY148457A (en)	2013-04-30
CA2654719A1 (en)	2007-12-21
AU2007259255A1 (en)	2007-12-21
EA015073B1 (ru)	2011-04-29
WO2007144421A1 (en)	2007-12-21
EA200970021A1 (ru)	2009-06-30

Similar Documents

Publication	Publication Date	Title
DK2023918T3 (da)	2011-04-26	Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
MX2009011359A (es)	2009-11-05	Derivados de pirimidinona y sus metodos de uso.
NO20081592L (no)	2008-05-23	Dipeptidylpeptidaseinhibitorer for behandling av diabetes
GEP20125701B (en)	2012-12-10	Application of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile
UY31526A1 (es)	2009-08-03	4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
NO20082768L (no)	2008-06-24	Levodopa prodroge mesylat, sammensetninger og anvendelser derav
NO20084752L (no)	2008-12-17	Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse
TNSN06053A1 (en)	2007-10-03	6-substituted anilino purines as rtk inhibitors
MX2009009416A (es)	2009-09-11	Derivados de bencimidazol y sus metodos de uso.
BR112012027759A2 (pt)	2017-08-15	Conjugados de peptídeos de agonistas de receptores glp-1 e gastrina e seu uso
TW200633992A (en)	2006-10-01	Biaryloxymethylarenecarboxylic acids
NO20090165L (no)	2009-01-12	Kombinasjonsfremstillinger innbefattende bifeprunox og L-DOPA
MX2009011358A (es)	2009-11-05	Derivados de pirimidinona y metodos para su uso.
NO20085257L (no)	2009-01-19	Purinonderivater som HM74a-agonister
NO20073651L (no)	2007-09-10	Antiangiogeneseterapi av autoimmunsykdom hos pasienter med mislykket tidligere terapi
MX2009011357A (es)	2009-11-05	Derivados de tetrahidropirido[4,3-d] pirimidinona y metodos de uso de los mismos.
WO2009071689A3 (de)	2009-07-23	5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
DK2013166T3 (da)	2010-07-05	N-carbamoylmethyl-4(R)-phenyl-2-pyrrolidon, fremgangsmåde til fremstilling heraf og farmaceutisk anvendelse
UA92730C2 (ru)	2010-12-10	Аналоги бензазола и их применение
HK1097774A1 (en)	2007-07-06	Stable pharmaceutical composition comprising linezolid from iv
WO2009068708A3 (es)	2009-07-16	Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo
DK2175877T3 (da)	2012-04-16	Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme
NO20090164L (no)	2009-01-14	Kombinasjonsfremstillinger innbefattende SLV308 og en L-DOPA
WO2007144699A3 (en)	2010-10-21	Process for the preparation of alfuzosin
CY1116166T1 (el)	2017-02-08	Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori

Legal Events

Date	Code	Title	Description
2014-02-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application